The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome
Open accessAbstract
Background: Mast cell activation is thought to be involved in visceral hypersensitivity, one of the main characteristics of the irritable bowel syndrome (IBS). A study was therefore undertaken to investigate the effect of the mast cell stabiliser ketotifen on rectal sensitivity and symptoms in patients with IBS. Methods: 60 patients with IBS underwent a barostat study to assess rectal sensitivity before and after 8 weeks of treatment. After the initial barostat, patients were randomised to receive ketotifen or placebo. IBS symptoms and health-related quality of life were scored. In addition, mast cells were quantified and spontaneous release of tryptase and histamine was determined in rectal biopsies and compared with biopsies from 22 age- and gender-matched healthy volunteers. Results: Ketotifen but not placebo increased the threshold for discomfort in patients with IBS with visceral hypersensitivity. This effect was not observed in normosensitive patients with IBS. Ketotifen significantly decreased abdominal pain and other IBS symptoms and improved quality of life. The number of mast cells in rectal biopsies and spontaneous release of tryptase were lower in patients with IBS than in healthy volunteers. Spontaneous release of histamine was mostly undetectable but was slightly increased in patients with IBS compared with healthy volunteers. Histamine and tryptase release were not altered by ketotifen. Conclusions: This study shows that ketotifen increases the threshold for discomfort in patients with IBS with visceral hypersensitivity, reduces IBS symptoms and improves health-related quality of life. Whether this effect is secondary to the mast cell stabilising properties of ketotifen or H 1 receptor antagonism remains to be further investigated. Trial Registration Number: NTR39, ISRCTN22504486 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bunnett, N. W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.055 · Cited by 1,475
Svedlund, J., Sj�din, I., & Dotevall, G. (1988) · Digestive Diseases and Sciences · doi:10.1007/bf01535722 · Cited by 1,468
The physiology of brain histamine
Brown, R. E., Stevens, D. R., & Haas, H. L. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00039-3 · Cited by 988
Mast Cell-Dependent Excitation of Visceral-Nociceptive Sensory Neurons in Irritable Bowel Syndrome
Barbara, G., Wang, B., Stanghellini, V., de Giorgio, R., Cremon, C., Di Nardo, G., Trevisani, M., Campi, B., Geppetti, P., Tonini, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.039 · Cited by 783
Role for protease activity in visceral pain in irritable bowel syndrome
Cenac, N., Andrews, C. N., Holzhausen, M., Chapman, K., Cottrell, G., Andrade-Gordon, P., Steinhoff, M., Barbara, G., Beck, P., Bunnett, N. W., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29255 · Cited by 591 · cited 1×
“Fourth, exposure to the supernatant obtained from colonic biopsies of patients with IBS but not from healthy controls increases the excitability of rat mesenteric sensory nerves and induces visceral hypersensitivity in mice.(8) 9 Finally, in animal models, administration of the mast cell stabiliser doxantrazole preven…”
Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum
Guilarte, M., Santos, J., de Torres, I., Alonso, C., Vicario, M., Ramos, L., Martinez, C., Casellas, F., Saperas, E., & Malagelada, J. R. (2007) · Gut · doi:10.1136/gut.2006.100594 · Cited by 385
Buhner, S., Li, Q., Vignali, S., Barbara, G., De Giorgio, R., Stanghellini, V., Cremon, C., Zeller, F., Langer, R., Daniel, H., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.005 · Cited by 351
Self-citationStress‐induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells
GUÉ, M., DEL RIO‐LACHEZE, C., EUTAMENE, H., THÉODOROU, V., FIORAMONTI, J., & BUÉNO, L. (1997) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.1997.d01-63.x · Cited by 282
Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis
Schwartz, L. B., Bradford, T. R., Rouse, C., Irani, A.-M., Rasp, G., Van Der Zwan, J. K., & Van Der Linden, P.-W. G. (1994) · Journal of Clinical Immunology · doi:10.1007/bf01533368 · Cited by 263
Histamine receptors are hot in immunopharmacology
Akdis, C. A., & Simons, F. E. R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.044 · Cited by 260
Grant, S. M., Goa, K. L., Fitton, A., & Sorkin, E. M. (1990) · Drugs · doi:10.2165/00003495-199040030-00006 · Cited by 238
Kuiken, S. D., Tytgat, G. N. J., & Boeckxstaens, G. E. E. (2003) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)70039-1 · Cited by 203
Self-citationPiche, T., Saint-Paul, M. C., Dainese, R., Marine-Barjoan, E., Iannelli, A., Montoya, M. L., Peyron, J. F., Czerucka, D., Cherikh, F., Filippi, J., et al. (2008) · Gut · doi:10.1136/gut.2007.127068 · Cited by 198
Naliboff, B. D., Berman, S., Suyenobu, B., Labus, J. S., Chang, L., Stains, J., Mandelkern, M. A., & Mayer, E. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.014 · Cited by 197
PARK, J. H., RHEE, P., KIM, H. S., LEE, J. H., KIM, Y., KIM, J. J., & RHEE, J. C. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04143.x · Cited by 196 · cited 1×
“Similarly, in patients with IBS, an increased number of mast cells is found in the small intestine,(4) large intestine(5) 6 and rectum.(7) Second, the number of mucosal mast cells and proximity to sensory nerves in colonic tissue is positively correlated to abdominal pain.”
Sander, L. E., Lorentz, A., Sellge, G., Coëffier, M., Neipp, M., Veres, T., Frieling, T., Meier, P. N., Manns, M. P., & Bischoff, S. C. (2006) · Gut · doi:10.1136/gut.2004.061762 · Cited by 173
Self-citationFunctional GI disorders: from animal models to drug development
Mayer, E. A., Bradesi, S., Chang, L., Spiegel, B. M. R., Bueller, J. A., & Naliboff, B. D. (2008) · Gut · doi:10.1136/gut.2006.101675 · Cited by 162
Delvaux, M. M., Louvel, D., Lagier, E., Scherrer, B., Abitbol, J., & Frexinos, J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70226-x · Cited by 158
Stefanini, G. F., Saggioro, A., Alvisi, V., Angelini, G., Capurso, L., Lorenzo, G. D., Dobrilla, G., Dodero, M. C. R., Galimberti, M., Gasbarrini, A., et al. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509089786 · Cited by 147
Mast cells and nerves tickle in the tummy
Rijnierse, A., Nijkamp, F. P., & Kraneveld, A. D. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.008 · Cited by 105
Kuiken, S., Lindeboom, R., Tytgat, G. N. J., & Boeckxstaens, G. E. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02524.x · Cited by 101
Self-citationMast Cell-restricted Tryptases: Structure and Function in Inflammation and Pathogen Defense
McNeil, H. P., Adachi, R., & Stevens, R. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700017200 · Cited by 97
Eutamène, H., Théodorou, V., Fioramonti, J., & Bueno, L. P. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.052274 · Cited by 82
Alosetron and irritable bowel syndrome
Mayer, E. A., & Bradesi, S. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.11.2089 · Cited by 81
de la Serna, H., Porras, M., & Vergara, P. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104620 · Cited by 75
LUNARDI, C., BAMBARA, L. M., BIASI, D., CORTINA, P., PEROLI, P., NICOLIS, F., FAVARI, F., & PACOR, M. L. (1991) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1991.tb00848.x · Cited by 72
Smith, E. A., & Macfarlane, G. T. (1996) · Anaerobe · doi:10.1006/anae.1996.0037 · Cited by 67
Candidate genes and sensory functions in health and irritable bowel syndrome
Camilleri, M., Busciglio, I. A., Carlson, P., McKinzie, S., Burton, D. D., Baxter, K. L., Ryks, M. D., & Zinsmeister, A. R. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90202.2008 · Cited by 66
Kuiken, S. D., Tytgat, G. N. J., & Boeckxstaens, G. E. (2003) · Clinical Gastroenterology and Hepatology · doi:10.1053/cgh.2003.50032 · Cited by 49
Self-citationPossible role of nitric oxide in visceral hypersensitivity in patients with irritable bowel syndrome
Kuiken, S., Klooker, T. K., Tytgat, G. N. J., Lei, A., & Boeckxstaens, G. E. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00731.x · Cited by 46
Self-citationTargeting mast cells in the treatment of functional gastrointestinal disorders
Santos, J., Alonso, C., Guilarte, M., Vicario, M., & Malagelada, J. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.001 · Cited by 44
In Vitro Inhibition of Human Conjunctival Mast-Cell Degranulation by Ketotifen
Schoch, C. (2003) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076803762718132 · Cited by 37
Use of oral sodium cromoglycate in persistent diarrhoea.
Bolin, T. D. (1980) · Gut · doi:10.1136/gut.21.10.848 · Cited by 34
Ketotifen Treatment of Active Colitis in Patients with 5‐Aminosalicylate Intolerance
Marshall, J. K., & Irvine, E. J. (1998) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/1998/398142 · Cited by 34
Lipid‐induced colonic hypersensitivity in irritable bowel syndrome: the role of 5‐HT3 receptors
Simrén, M., Simms, L., D'Souza, D. L., Abrahamsson, H., & Björnsson, E. S. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01399.x · Cited by 29
Mast Cell-Dependent Excitation of Visceral-Nociceptive Sensory Neurons in Irritable Bowel Syndrome
Katzka, D. A. (2008) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)79140-2 · Cited by 24
Role of histaminergic neurons in hypnotic modulation of brain processing of visceral perception
Watanabe, S., Hattori, T., Kanazawa, M., Kano, M., & Fukudo, S. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00959.x · Cited by 20
Reduced immunostaining for c‐kit receptors in mucosal mast cells in inflammatory bowel disease
Farhadi, A., Keshavarzian, A., Fields, J. Z., Jakate, S. M., Shaikh, M. W., & Banan, A. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05011.x · Cited by 17
Cited by
Intestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755
Self-citationRajilić–Stojanović, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., & de Vos, W. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.043 · Cited by 1,041
Vanuytsel, T., van Wanrooy, S., Vanheel, H., Vanormelingen, C., Verschueren, S., Houben, E., Salim Rasoel, S., Tόth, J., Holvoet, L., Farré, R., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305690 · Cited by 615
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial
McIntosh, K., Reed, D. E., Schneider, T., Dang, F., Keshteli, A. H., De Palma, G., Madsen, K., Bercik, P., & Vanner, S. (2017) · Gut · doi:10.1136/gutjnl-2015-311339 · Cited by 478
Camilleri, M., Lasch, K., & Zhou, W. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00155.2012 · Cited by 396
Metadata
- Authors
- Klooker, T. K., Braak, B., Koopman, K. E., Welting, O., Wouters, M. M., van der Heide, S., Schemann, M., Bischoff, S. C., van den Wijngaard, R. M., & Boeckxstaens, G. E.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2010-07-21
- Volume
- 59
- Issue
- 9
- Pages
- 1213-1221
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2129921159
- Cited by
- 412
- References
- 38
- FWCI
- 31.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.